Ziping Wang

966 citations
23 papers · 676 · 2 hit papers · h-index 11

Impact in

    • Arsenic contamination and mitigation
    • Mine drainage and remediation techniques
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies

Papers in

    • Cancer Immunotherapy and Biomarkers 4
    • Lung Cancer Research Studies 2
    • Cytokine Signaling Pathways and Interactions 2
    • Cancer Genomics and Diagnostics 3

Ziping Wang

22 papers receiving 672 citations

Ziping Wang's Hit Papers

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer 2024 · 105 citations
1050+1+2Years since publication50100150

Peers

Ziping Wang
Comparison fields: 5 of 82
  • Environmental Chemistry 80
  • Oncology 175
  • Pulmonary and Respiratory Medicine 173
  • Pollution 54
  • Cancer Research 43
Replace Hong Shen with:
Hong Shen China
Wen‐Yang Hu United States
Yoko Sakuma Japan
Mona Sæbø Norway
Jiao-Yang Li China
Christopher E. Pedigo United States
Xiaozhao Li China
Santosh Yadav India
Yanmei Yang China
Ziping Wang relative to Hong Shen China Hong Shen's profile →
Citations per field
00.5×1.5×2.2×
Hong Shen · 1×
Citations per year

Countries citing papers authored by Ziping Wang

Since Specialization
Citations

This map shows the geographic impact of Ziping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziping Wang more than expected).

Fields of papers citing papers by Ziping Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziping Wang. The network helps show where Ziping Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Ziping Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ziping Wang Line = papers co-authored together Ziping Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial
Hit paper breakdown →
2022178
2
Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer
Hit paper breakdown →
2024105
3 201995
4 200581
5 200555
6 201325
7 202124
8 202315
9 202415
10 200212
11 202212
12 202310
13 202510
14 20257
15 20247
16 20216
17 20236
18 20245
19 20243
20 20242

About Ziping Wang

Ziping Wang is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Environmental Chemistry and Pathology and Forensic Medicine, having authored 23 papers that have together received 676 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Genomics and Diagnostics (3 papers), Lung Cancer Research Studies (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Nitric Oxide and Endothelin Effects (2 papers), Renin-Angiotensin System Studies (1 paper) and Genomics and Phylogenetic Studies (1 paper). The work is most often cited by research in Environmental Chemistry (80 citations), Oncology (175 citations), Pulmonary and Respiratory Medicine (173 citations), Pollution (54 citations) and Cancer Research (43 citations). Ziping Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Thomas H. Hintze, Michael S. Wolin, Pawel M. Kaminski, Shintaro Kinugawa, Harer Huang, Jun Zhang, Peter Martin Kopittke, Ruben Kretzschmar, Chuan Chen and Fang-Jie Zhao. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology, Free Radical Biology and Medicine, Signal Transduction and Targeted Therapy and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact